John Burns
Director of Finance/CFO bij SELLAS LIFE SCIENCES GROUP, INC.
Vermogen: 94 352 $ op 31-03-2024
Profiel
John T.
Burns is currently the Chief Financial Officer & Accounting Officer, SVP at SELLAS Life Sciences Group, Inc. He previously worked as the Manager-Securities & Exchange Reporting at Pixelworks, Inc. and as the Chief Accounting Officer at Galena Biopharma, Inc. Mr. Burns completed his undergraduate and graduate degrees at Tulane University (Louisiana).
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
22-01-2024 | 93 418 ( 0.17% ) | 94 352 $ | 31-03-2024 |
Actieve functies van John Burns
Bedrijven | Functie | Begin |
---|---|---|
SELLAS LIFE SCIENCES GROUP, INC. | Director of Finance/CFO | 30-12-2017 |
Eerdere bekende functies van John Burns
Bedrijven | Functie | Einde |
---|---|---|
PIXELWORKS, INC. | Corporate Officer/Principal | - |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | - |
Opleiding van John Burns
Tulane University (Louisiana) | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PIXELWORKS, INC. | Electronic Technology |
SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |